Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05245773 · ClinicalTrials.gov registry record · NA

MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
5,000
Enrollment target

NCT05245773: Completed NA study, sponsored by University of Pennsylvania.

NCT05245773 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 5,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (256% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05245773, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
5,000 participants
Enrollment target

Study Summary

This study will evaluate a 30-day post-discharge intervention using an automated SMS platform to monitor patients and facilitate communication with their primary care practice. The population will be patients who receive care from participating practices and are discharged from an inpatient stay. In addition to the usual phone call from their practice, patients will be randomized to enrollment in the program, wherein they will receive automated SMS messages on a tapering schedule over 30 days.

Primary Outcome

A composite, binary measure indicating whether a patient visited the ED or was readmitted to inpatient care after discharge from the hospital.

Interventions

  • OTHER Automated SMS program to support post-discharge transitions of care

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2022-03-29
Est. Completion 2023-02-03
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05245773 record still lists

NCT05245773 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (256% higher).

The record links to 0 conditions, and to 1 intervention - of which Automated SMS program to support post-discharge transitions of care is the first listed.

NCT05245773 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05245773 about?

NCT05245773 is a clinical study titled "MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care". This study will evaluate a 30-day post-discharge intervention using an automated SMS platform to monitor patients and facilitate communication with their primary care practice. The population will be patients who receive care from participating practices and are discharged from an inpatient stay. In...

What is the current status of trial NCT05245773?

This trial is currently completed. It is a NA study. The enrollment target is 5,000 participants. The study started on 2022-03-29. Estimated completion is 2023-02-03.

What interventions are being tested in trial NCT05245773?

The interventions under investigation include: Automated SMS program to support post-discharge transitions of care (OTHER).

Who is sponsoring clinical trial NCT05245773?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05245773's enrollment target sits among peer trials

5,000 25th of 2000 higher than 1,973 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05245773, the US trial registry maintained by the National Library of Medicine. NCT05245773 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.